Retinoic acid promotes mouse splenic B cell surface IgG expression and maturation stimulated by CD40 and IL-4

Cellular Immunology

Volumn 249, Issue 1, 2007, Pages 37-45

  Chen, Qiuyan ^a   Ross, A Catharine ^a,b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

AID; B cell; Blimp 1; CD138; CD40; Cell division; Class switch; Germline transcript; IL 4; Maturation; Retinoic acid

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD40 ANTIGEN; DEAMINASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; INTERLEUKIN 4; LYMPHOCYTE ANTIGEN RECEPTOR; RETINOIC ACID; SYNDECAN 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL SURFACE; CYTOKINE PRODUCTION; FEMALE; HUMORAL IMMUNITY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; INTERLEUKIN-4; MALE; MICE; NUCLEOSIDE DEAMINASES; REPRESSOR PROTEINS; SPLEEN; SYNDECAN-1; TRANSCRIPTION FACTORS; TRETINOIN;

EID: 38349194826     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2007.11.001     Document Type: Article

References (58)

1. Baumgarth N. A two-phase model of B-cell activation. Immunol. Rev. 176 (2000) 171-180
2. Schonbeck U., and Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol. Life Sci. 58 (2001) 4-43
3. Bishop G.A., and Hostager B.S. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev. 14 (2003) 297-309
4. Neron S., Racine C., Roy A., and Guerin M. Differential responses of human B-lymphocyte subpopulations to graded levels of CD40-CD154 interaction. Immunology 116 (2005) 454-463
5. Noelle R.J., and Erickson L.D. Determinations of B cell fate in immunity and autoimmunity. Curr. Dir. Autoimmun. 8 (2005) 1-24
6. Benson M.J., Erickson L.D., Gleeson M.W., and Noelle R.J. Affinity of antigen encounter and other early B-cell signals determine B-cell fate. Curr. Opin. Immunol. 19 (2007) 275-280
7. van Kooten C., and Banchereau J. CD40-CD40 ligand. J. Leukoc. Biol. 67 (2000) 2-17
8. Chan W.L., Pejnovic N., Liew T.V., and Hamilton H. Predominance of Th2 response in human abdominal aortic aneurysm: mistaken identity for IL-4-producing NK and NKT cells?. Cell Immunol. 233 (2005) 109-114
9. Huntington N.D., Xu Y., Puthalakath H., Light A., Willis S.N., Strasser A., and Tarlinton D.M. CD45 links the B cell receptor with cell survival and is required for the persistence of germinal centers. Nat. Immunol. 7 (2006) 190-198
10. Haxhinasto S.A., and Bishop G.A. A novel interaction between protein kinase D and TNF receptor-associated factor molecules regulates B cell receptor-CD40 synergy. J. Immunol. 171 (2003) 4655-4662
11. Haxhinasto S.A., and Bishop G.A. Synergistic B cell activation by CD40 and the B cell antigen receptor: role of B lymphocyte antigen receptor-mediated kinase activation and tumor necrosis factor receptor-associated factor regulation. J. Biol. Chem. 279 (2004) 2575-2582
12. Ross A.C. Retinoid production and catabolism: role of diet in regulating retinol esterification and retinoic Acid oxidation. J. Nutr. 133 (2003) 291S-296S
13. Bastien J., and Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328 (2004) 1-16
14. Ballow M., Wang X., Xiang S., and Allen C. Expression and regulation of nuclear retinoic acid receptors in human lymphoid cells. J. Clin. Immunol. 23 (2003) 46-54
15. Morikawa K., and Nonaka M. All-trans-retinoic acid accelerates the differentiation of human B lymphocytes maturing into plasma cells. Int. Immunopharmacol. 5 (2005) 1830-1838
16. Ross A.C. Vitamin A, retinoids and immune responses. In: Livrea M.A. (Ed). Vitamin A and Retinoids: An Update of Biological Aspects and Clinical Application (2000), Birkauser Verlag, Basel/Switzerland
17. Stephensen C.B. Vitamin A, infection, and immune function. Annu. Rev. Nutr. 21 (2001) 167-192
18. Semba R.D., Farzadegan H., and Vlahov D. Vitamin A levels and human immunodeficiency virus load in injection drug users. Clin. Diagn. Lab. Immunol. 4 (1997) 93-95
19. Kirkwood B.R., Arthur P., Ross D.A., Morris S.S., Gyapong J.O., and Tomkins A.M. Vitamin A supplementation in Northern Ghana: effects on clinic attendances, hospital admissions, and child mortality. Lancet 342 (1993) 7-12
20. Ross A.C., and Stephensen C.B. Vitamin A and retinoids in antiviral responses. FASEB J. 10 (1996) 979-985
21. Villamor E., and Fawzi W.W. Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes. Clin. Microbiol. Rev. 18 (2005) 446-464
22. Glasziou P.P., and Mackerras D.E. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ 306 (1993) 366-370
23. Cui D., Moldoveanu Z., and Stephensen C.B. High-level dietary vitamin A enhances T-helper type 2 cytokine production and secretory immunoglobulin A response to influenza A virus infection in BALB/c mice. J. Nutr. 130 (2000) 1132-1139
24. Hoag K.A., Nashold F.E., Goverman J., and Hayes C.E. Retinoic acid enhances the T helper 2 cell development that is essential for robust antibody responses through its action on antigen-presenting cells. J. Nutr. 132 (2002) 3736-3739
25. Ma Y., Chen Q., and Ross A.C. Retinoic acid and polyriboinosinic:polyribocytidylic acid stimulate robust anti-tetanus antibody production while differentially regulating type 1/type 2 cytokines and lymphocyte populations. J. Immunol. 174 (2005) 7961-7969
26. DeCicco K.L., Youngdahl J.D., and Ross A.C. All-trans-retinoic acid and polyriboinosinic:polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity. Immunology 104 (2001) 341-348
27. Ma Y., and Ross A.C. The anti-tetanus immune response of neonatal mice is augmented by retinoic acid combined with polyriboinosinic:polyribocytidylic acid. Proc. Natl. Acad. Sci. USA 102 (2005) 13556-13561
28. Blomhoff H.K. Vitamin A regulates proliferation and apoptosis of human T- and B-cells. Biochem. Soc. Trans. 32 (2004) 982-984
29. Chen Q., and Ross A.C. Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells. Proc. Natl. Acad. Sci. USA 102 (2005) 14142-14149
30. Blomhoff H.K., Smeland E.B., Erikstein B., Rasmussen A.M., Skrede B., Skjonsberg C., and Blomhoff R. Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells. J. Biol. Chem. 267 (1992) 23988-23992
31. Lomo J., Smeland E.B., Ulven S., Natarajan V., Blomhoff R., Gandhi U., Dawson M.I., and Blomhoff H.K. RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes. J. Cell Physiol. 175 (1998) 68-77
32. Deaglio S., Capobianco A., Bergui L., Durig J., Morabito F., Duhrsen U., and Malavasi F. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood 102 (2003) 2146-2155
33. Andjelic S., Hsia C., Suzuki H., Kadowaki T., Koyasu S., and Liou H.C. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways. J. Immunol. 165 (2000) 3860-3867
34. Linehan L.A., Warren W.D., Thompson P.A., Grusby M.J., and Berton M.T. STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination. J. Immunol. 161 (1998) 302-310
35. Mizuno T., and Rothstein T.L. B cell receptor (BCR) cross-talk: CD40 engagement creates an alternate pathway for BCR signaling that activates I kappa B kinase/I kappa B alpha/NF-kappa B without the need for PI3K and phospholipase C gamma. J. Immunol. 174 (2005) 6062-6070
36. De Leenheer A.P., Lambert W.E., and Claeys I. All-trans-retinoic acid: measurement of reference values in human serum by high performance liquid chromatography. J. Lipid Res. 23 (1982) 1362-1367
37. Chen Q., Ma Y., and Ross A.C. Opposing cytokine-specific effects of all trans-retinoic acid on the activation and expression of signal transducer and activator of transcription (STAT)-1 in THP-1 cells. Immunology 107 (2002) 199-208
38. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., and Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 (2000) 553-563
39. Hasbold J., Corcoran L.M., Tarlinton D.M., Tangye S.G., and Hodgkin P.D. Evidence from the generation of immunoglobulin G-secreting cells that stochastic mechanisms regulate lymphocyte differentiation. Nat. Immunol. 5 (2004) 55-63
40. Hasbold J., Lyons A.B., Kehry M.R., and Hodgkin P.D. Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4. Eur. J. Immunol. 28 (1998) 1040-1051
41. Lanzavecchia A., and Sallusto F. Progressive differentiation and selection of the fittest in the immune response. Nat. Rev. Immunol. 2 (2002) 982-987
42. Shinagawa T., Nunoi H., Nonoyama S., and Kanegasaki S. Induction of CD40 in promyelocytic HL60 cells cultured with retinoic acid and/or various cytokines. J. Biochem. (Tokyo) 118 (1995) 534-540
43. Park H.Y., Park J.Y., Kim J.W., Lee M.J., Jang M.J., Lee S.Y., Baek D.W., Park Y.M., Lee S.W., Yoon S., Bae Y.S., and Kwak J.Y. Differential expression of dendritic cell markers by all-trans retinoic acid on human acute promyelocytic leukemic cell line. Int. Immunopharmacol. 4 (2004) 1587-1601
44. Moodycliffe A.M., Shreedhar V., Ullrich S.E., Walterscheid J., Bucana C., Kripke M.L., and Flores-Romo L. CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes. J. Exp. Med. 191 (2000) 2011-2020
45. Worm M., Krah J.M., Manz R.A., and Henz B.M. Retinoic acid inhibits CD40 + interleukin-4-mediated IgE production in vitro. Blood 92 (1998) 1713-1720
46. Worm M., Herz U., Krah J.M., Renz H., and Henz B.M. Effects of retinoids on in vitro and in vivo IgE production. Int. Arch. Allergy Immunol. 124 (2001) 233-236
47. Scheffel F., Heine G., Henz B.M., and Worm M. Retinoic acid inhibits CD40 plus IL-4 mediated IgE production through alterations of sCD23, sCD54 and IL-6 production. Inflamm. Res. 54 (2005) 113-118
48. Nambu Y., Sugai M., Gonda H., Lee C.G., Katakai T., Agata Y., Yokota Y., and Shimizu A. Transcription-coupled events associating with immunoglobulin switch region chromatin. Science 302 (2003) 2137-2140
49. Jabara H.H., and Geha R.S. Jun N-terminal kinase is essential for CD40-mediated IgE class switching in B cells. J. Allergy Clin. Immunol. 115 (2005) 856-863
50. Kaku H., Horikawa K., Obata Y., Kato I., Okamoto H., Sakaguchi N., Gerondakis S., and Takatsu K. NF-kappaB is required for CD38-mediated induction of C(gamma)1 germline transcripts in murine B lymphocytes. Int. Immunol. 14 (2002) 1055-1064
51. Carlsen H., Alexander G., Austenaa L.M., Ebihara K., and Blomhoff R. Molecular imaging of the transcription factor NF-kappaB, a primary regulator of stress response. Mutat. Res. 551 (2004) 199-211
52. Salmon R.A., Foltz I.N., Young P.R., and Schrader J.W. The p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptors, Fas or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors. J. Immunol. 159 (1997) 5309-5317
53. Feng B., Cheng S., Hsia C.Y., King L.B., Monroe J.G., and Liou H.C. NF-kappaB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival. Cell Immunol. 232 (2004) 9-20
54. Craxton A., Shu G., Graves J.D., Saklatvala J., Krebs E.G., and Clark E.A. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. J. Immunol. 161 (1998) 3225-3236
55. Chen Q., and Ross A.C. Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells. Exp. Cell Res. 297 (2004) 68-81
56. Johnson K., Shapiro-Shelef M., Tunyaplin C., and Calame K. Regulatory events in early and late B-cell differentiation. Mol. Immunol. 42 (2005) 749-761
57. Cattoretti G., Angelin-Duclos C., Shaknovich R., Zhou H., Wang D., and Alobeid B. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage. J. Pathol. 206 (2005) 76-86
58. Bergthorsdottir S., Gallagher A., Jainandunsing S., Cockayne D., Sutton J., Leanderson T., and Gray D. Signals that initiate somatic hypermutation of B cells in vitro. J. Immunol. 166 (2001) 2228-2234